Clinical Trial Update: CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating CDK4/6 inhibition in locally advanced or metastatic chordoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chordoma

Snippet

Sponsor: University Hospital Heidelberg | Conditions: Chordoma | Phase 2 | Status: COMPLETED